# Vishnu Chemicals share price today (Vishnu Chemicals Ltd, NSE: VISHNU) > Vishnu Chemicals share price today: ₹551.95 at the NSE close on 18 November 2026, up 14.8% in a year. Vishnu Chemicals (NSE: VISHNU) is worth ₹3,713 crore, trades at a P/E of 24.4 and has closed between ₹480.85 and ₹722.15 over the past 52 weeks. > Vishnu Chemicals Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. VISHNU · Speciality Chemicals · data as of 18 November 2026. Page: https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Business trend: Mixed, from the last 12 quarters - Price: ₹551.95 (+14.8% in a year) - P/E: 24.4× (higher than 65% of the last 11 years) - Revenue (Sep 2026): ₹430 Cr (+7.2% on a year ago) - Profit (Sep 2026): ₹36.0 Cr (+9.1% on a year ago) - Operating margin: 14.9% (+0.4 points on a year ago) - ROCE: 16%, FY26 - ROIC: 9.8%, against a 12.0% cost of capital: −2.2 points Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work. ## What is the Vishnu Chemicals share price today? Vishnu Chemicals Ltd's share price was ₹551.95 at the close on 18 November 2026. It is in an uptrend that has just slipped below its 200-day average. That is 6.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹481 and ₹722, and at that close it sat 29% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running. Over the last 11 years the share price moved +1,566% while the NIFTY 500 moved +306%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Vishnu Chemicals this quarter? Two changes stood out: revenue up on a year earlier for 10 quarters in a row and foreign funds (FIIs) raised their stake for 3 quarters in a row. 1. Revenue up on a year earlier for 10 quarters in a row In the September 2026 quarter revenue was ₹430 crore, +7.2% on a year earlier. Why: Revenue rose because the company shifted its chromium product mix to oxide and acid, with European orders and domestic demand helping. Next results: check whether base chrome sales lost to high shipping costs return in Q4. From the earnings call on 6 Nov 2026. 2. Foreign funds (FIIs) raised their stake for 3 quarters in a row From 2.2% to 2.5% of the company by the September 2026 quarter. ## What are Vishnu Chemicals' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Vishnu Chemicals reported revenue of ₹430 crore, up 7.2% from ₹401 crore a year earlier, and a profit of ₹36.0 crore, up 9.1% from ₹33.0 crore. ### Vishnu Chemicals results: July to September 2026 against a year earlier | Measure | July to September 2026 | July to September 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹430 crore | ₹401 crore | +7.2% | | Profit | ₹36.0 crore | ₹33.0 crore | +9.1% | | Earnings per share | ₹5.28 | ₹4.88 | +8.2% | | Operating margin | 14.9% | 14.5% | +0.4 points | The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Vishnu Chemicals' management discussed these results on a call held on 6 November 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.) ## What is the Vishnu Chemicals share price history? Vishnu Chemicals closed at ₹551.95 on 18 November 2026, up 14.8% from ₹480.85 a year earlier (21 November 2025) and up 224.1% over five years. Its highest weekly close since February 2016 was ₹722.15 on 18 September 2026. ### Vishnu Chemicals share price: then and now | When | Close | Change to 18 Nov 2026 | | --- | --- | --- | | 1 week ago · 11 Nov 2026 | ₹556.20 | −0.8% | | 1 month ago · 19 Oct 2026 | ₹615.60 | −10.3% | | 6 months ago · 15 May 2026 | ₹573.00 | −3.7% | | 1 year ago · 21 Nov 2025 | ₹480.85 | +14.8% | | 3 years ago · 17 Nov 2023 | ₹314.95 | +75.3% | | 5 years ago · 18 Nov 2021 | ₹170.28 | +224.1% | | 10 years ago · 18 Nov 2016 | ₹49.44 | +1,016.4% | | Earliest weekly close in our records · 26 Feb 2016 | ₹33.13 | +1,566.0% | | Highest weekly close since February 2016, also the 52-week high · 18 Sep 2026 | ₹722.15 | −23.6% | | Lowest weekly close since February 2016 · 27 Mar 2020 | ₹13.37 | +4,028.3% | | 52-week low (weekly close) · 21 Nov 2025 | ₹480.85 | +14.8% | Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (569 weekly closes from 26 February 2016 to 18 November 2026.) ## What is the latest news on Vishnu Chemicals? 18 Nov 2026: Vishnu Chemicals closed at ₹551.95, down 0.8% on the week and down 10.3% on the month. 6 Nov 2026: Vishnu Chemicals held its results call for July to September 2026. Management guided: DMSO operations from April to June 2027 aiming for 50-60% operating level in first year with short stabilisation. ### Earlier - Results for July to September 2026: Revenue up 7.2% and profit up 9.1% on a year earlier. - 21 Aug 2026: ex-date for a dividend of ₹0.30 a share. ## What dividend does Vishnu Chemicals pay? Vishnu Chemicals paid ₹0.30 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 0.05% at the ₹551.95 close on 18 November 2026. The last was a dividend of ₹0.30 a share, ex-date 21 August 2026. ### Vishnu Chemicals dividends since 1 April 2021 | Ex-date | Dividend per share | Type | Record date | | --- | --- | --- | --- | | 21 Aug 2026 | ₹0.30 | Dividend | same day | | 8 Aug 2025 | ₹0.30 | Dividend | same day | | 20 Sep 2024 | ₹0.30 | Dividend | n/a | | 4 Aug 2023 | ₹0.40 | Dividend | n/a | | 7 Jul 2022 | ₹2 | Dividend | n/a | | 1 Jul 2021 | ₹1 | Dividend | 2 Jul 2021 | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record Yes. Vishnu Chemicals Ltd paid out 1% of its profit as dividends in FY26, and it paid a dividend in 11 of its last 13 reported years. (From the NSE corporate-actions record, read 18 November 2026.) ## What did Vishnu Chemicals management say on the latest results call? On the call for July to September 2026, held on 6 November 2026, Vishnu Chemicals' management guided: DMSO operations from April to June 2027 aiming for 50-60% operating level in first year with short stabilisation. > “During the quarter gone by, our shipping and forwarding expense increased to 8.8% of operating revenue compared to 5.9% in the preceding quarter of this financial year.” > Siddarth Cherukuri, on the call for July to September 2026 ### What management guided - Strontium optimum 70% utilisation next year on import substitution with approvals converting. - South Africa ore shipments to India from January to March 2027 with significant contribution next year. - Chromium-metal joint venture aiming for above 20% operating profit with India Phase-1 from January to March 2028. - Remaining capital spending ₹300-330Cr over next year of ₹524 crore total with ₹190 crore spent; DMSO ₹250 crore and oxide ₹220 crore; peak debt ₹800-820Cr versus ₹717 crore now. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/1881/Conference Call/CC-Nov26.pdf). (From the call for July to September 2026, 6 November 2026.) ## What to watch in Vishnu Chemicals' next results? When Vishnu Chemicals reports October to December 2026, these are the 3 checks that show whether the story is still on course. First: Parwada restart and Q3 sales impact vs no-loss claim - verify resumption intimation and output. Management raised each of these on the latest results call. - Parwada restart and Q3 sales impact vs no-loss claim - verify resumption intimation and output. - Westbound freight cost and base-chrome volumes - check normalisation from spike with volume return. - South Africa beneficiation output and first India ore transfer - track commissioning progress and shipment. ## Which stock lists is Vishnu Chemicals on? Vishnu Chemicals is not on any of our India lists this week. ## Is Vishnu Chemicals profitable? Vishnu Chemicals Ltd earned ₹36.0 Cr of net profit in the Sep 2026 quarter, +9.1% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹142 Cr. Over 10 years profit has grown 21.1% a year on average. The same quarter a year earlier earned ₹33.0 Cr. The Sep 2026 quarter's profit is 8.4% of that quarter's revenue. For the full year, FY26 profit was ₹142 Cr (+11.8% on the year before). Why profit moved: revenue changed +7.2% on a year earlier and the margin moved +0.4 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +11.1% and revenue +14.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Vishnu Chemicals make, and is it growing? Vishnu Chemicals Ltd reported ₹430 Cr of revenue in the Sep 2026 quarter, +7.2% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 10 years it has grown 12.9% a year on average. The last full year, FY26, came in at ₹1,610 Cr. The last four reported quarters add to ₹1,724 Cr. FY26 revenue was ₹1,610 Cr, +11.3% on the year before. Recent pace: the last four quarters grew +14.3% on average, against 12.9% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +14.0%, against +15.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +10.9%, against +22.5% a year (rolling over). ## How much of every ₹100 of sales does Vishnu Chemicals keep? Vishnu Chemicals Ltd's operating margin was 14.9% in the Sep 2026 quarter, 0.4 percentage points higher than the same quarter a year ago. Across 13 years it has been between 11.6% and 18.9%. The latest quarter is within that range. Why the margin moved: operating margin changed +0.4 percentage points on the year while gross margin changed +8.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Vishnu Chemicals' profit turning into cash? Over the last 3 years, 77% of Vishnu Chemicals Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹127 Cr of operating cash against ₹142 Cr of profit. After ₹257 Cr of spending on assets, free cash was −₹130 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 77% of profit came in as cash: the cash cycle got 18 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 18 days longer. The next section looks at where the cash is stuck. ## Where does Vishnu Chemicals' cash go? Vishnu Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 149 days in FY26, up from 131 days in FY21. It spent ₹465 Cr on assets over the last 3 years. Customers take 70 days to pay, and stock sits for 271 days on average. At FY26 sales of ₹1,610 Cr, each day of that cycle ties up about ₹4.4 Cr, so roughly ₹657 Cr is tied up in the business at any time. FY26: customers took 70 days to pay and stock sat for 271 days, about 8.9 months of sales sitting as stock, for a full cycle of 149 days, longer than FY21's 131. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 271 days. Customers pay about 70 days after that. Suppliers are paid at 193 days. Together that makes the 149-day cycle. Spending on assets: ₹465 Cr over the last 3 years, against ₹113 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹159 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Vishnu Chemicals' P/E ratio, and how does it compare with its own history? Vishnu Chemicals Ltd's P/E is 24.4×, in the middle of its own history: higher than 65% of past readings. Its usual P/E (the middle reading) is 17.4×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +12.3% while the price moved +14.8%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +26.5% a year; about +25.8% a year came from earnings growth and about +0.7 percentage points from the multiple (roughly no change); over 10 years the price moved +27.3% a year; about +20.3% a year came from earnings growth and about +7.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Vishnu Chemicals business getting better or worse? Vishnu Chemicals Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE falling at 17.2% (four quarters to Sep 2026); each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Vishnu Chemicals earn on its capital? Vishnu Chemicals Ltd earned a ROCE of 16% in FY26. That is up from a low of 12% in FY21. Its return on capital used (ROIC) is 2.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 8.8% net margin and 0.77× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 8.8% net margin × 0.77× asset turnover × 1.95× leverage (assets divided by equity) ≈ 13.2% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 9.8% − 12.0% = −2.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Vishnu Chemicals have too much debt? Vishnu Chemicals Ltd has total debt of ₹718 Cr against shareholder equity of ₹1,146 Cr as of Sep 2026, so its debt is 0.63× its equity. Year by year, that ratio went from 1.32 in FY22 to 0.49 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Vishnu Chemicals shareholding pattern? Foreign institutions raised their stake in Vishnu Chemicals Ltd by 1.6 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 2.5% of the company. Promoters moved +0.8 points over the same period, to 69.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +1.6 points over 8 quarters, to 2.5%; Promoters: +0.8 points over 8 quarters, to 69.2%; Domestic institutions: −0.7 points over 8 quarters, to 5.8%. Why the owners changed: foreign institutions drove it (+1.6 points), together with promoters (+0.8 points). They raised their stake step by step. ## How far is Vishnu Chemicals from balance-sheet trouble? For Vishnu Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Vishnu Chemicals rank in its industry? 37.6 out of 100, rank 29 of 30 in Speciality Chemicals, with 90% of the evidence available. Vishnu Chemicals Ltd scores 37.6 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 29. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 13.4 + 13.3 + 8.1 + 2.8 = 37.6. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Vishnu Chemicals compared with? Vishnu Chemicals ranks 29 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 37.6 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · losing its lead · Most evidence points up · 90% evidence 77.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 33.5/35 · Revenue 75% · Profit 100% · Operating margin change 8 points · 100% evidence Capital efficiency 17.2/25 · ROCE 19.2% (year to Mar 2026) · Operating margin 17.2% · 100% evidence Valuation 14.6/20 · P/E 3.8× · PEG n/a · 50% evidence Relative strength 11.9/20 · Strength vs its industry (price vs its 52-week average, weekly) 12.1% · Strength vs NIFTY 500 (same reading) 15.8% · 1 year 39.7% · 100% evidence · 8 of 12 weeks ahead Exact sum: 33.5 + 17.2 + 14.6 + 11.9 = 77.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · losing its lead · Most evidence points up · 85% evidence 67.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.0/35 · Revenue 30.2% · Profit 42.3% · Operating margin change 2 points · 100% evidence Capital efficiency 11.9/25 · ROCE 13.5% (year to Mar 2026) · Operating margin 10.5% · 100% evidence Valuation 16.2/20 · P/E 19.3× · PEG 1.14 · 100% evidence Relative strength 11.3/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 6.9% · 1 year 7.5% · 25% evidence · 11 of 12 weeks ahead Exact sum: 28 + 11.9 + 16.2 + 11.3 = 67.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Most evidence points up · 75% evidence 66.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.4/35 · Revenue 13% · Profit 65% · Operating margin change 5 points · 100% evidence Capital efficiency 14.8/25 · ROCE 18.7% (year to Mar 2026) · Operating margin 13.6% · 100% evidence Valuation 14.4/20 · P/E 15.3× · PEG n/a · 50% evidence Relative strength 9.8/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 0.6% · 1 year n/a · 25% evidence · 6 of 12 weeks ahead Exact sum: 27.4 + 14.8 + 14.4 + 9.8 = 66.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Evidence leans up · 68% evidence 64.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.6/25 · ROCE 8.9% (year to Mar 2026) · Operating margin 21% · 100% evidence Valuation 9.1/20 · P/E 52.1× · PEG n/a · 15% evidence Relative strength 12.2/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 44% · 1 year 126.5% · 25% evidence · 9 of 12 weeks ahead Exact sum: 30.4 + 12.6 + 9.1 + 12.2 = 64.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 100% evidence 61.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 100% · Profit 68.7% · Operating margin change -8 points · 100% evidence Capital efficiency 13.8/25 · ROCE 18.3% (year to Mar 2026) · Operating margin 15.5% · 100% evidence Valuation 9.1/20 · P/E 39.9× · PEG 1.13 · 100% evidence Relative strength 18.2/20 · Strength vs its industry (price vs its 52-week average, weekly) 42.8% · Strength vs NIFTY 500 (same reading) 45.9% · 1 year 81.3% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.8 + 13.8 + 9.1 + 18.2 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.9/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.8/25 · ROCE 7.2% (year to Mar 2026) · Operating margin 18.9% · 100% evidence Valuation 10.3/20 · P/E 61.3× · PEG 1.23 · 65% evidence Relative strength 13.1/20 · Strength vs its industry (price vs its 52-week average, weekly) 11.4% · Strength vs NIFTY 500 (same reading) 15.7% · 1 year 13.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 28.9 + 8.8 + 10.3 + 13.1 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 60.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.6/25 · ROCE 22.3% (year to Mar 2026) · Operating margin 26.3% · 76% evidence Valuation 9.8/20 · P/E 36× · PEG n/a · 50% evidence Relative strength 8.0/20 · Strength vs its industry (price vs its 52-week average, weekly) -3.5% · Strength vs NIFTY 500 (same reading) 0.9% · 1 year 9.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 23.6 + 18.6 + 9.8 + 8 = 60 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 72% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change -4 points · 95% evidence Capital efficiency 21.2/25 · ROCE 36.2% (year to Mar 2026) · Operating margin 40.9% · 95% evidence Valuation 7.4/20 · P/E 21.7× · PEG n/a · 50% evidence Relative strength 12.0/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 39.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 18.8 + 21.2 + 7.4 + 12 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · losing its lead · Evidence leans up · 100% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.4/35 · Revenue 39.8% · Profit 100% · Operating margin change -3 points · 100% evidence Capital efficiency 9.8/25 · ROCE 6.9% (year to Mar 2026) · Operating margin 11.2% · 100% evidence Valuation 13.7/20 · P/E 28.3× · PEG 0.93 · 100% evidence Relative strength 9.1/20 · Strength vs its industry (price vs its 52-week average, weekly) -0.6% · Strength vs NIFTY 500 (same reading) 4% · 1 year 20.2% · 100% evidence · 4 of 12 weeks ahead Exact sum: 26.4 + 9.8 + 13.7 + 9.1 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 75% evidence 55.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.1/35 · Revenue 22.3% · Profit 20.2% · Operating margin change 4.1 points · 100% evidence Capital efficiency 8.8/25 · ROCE 6.3% (year to Mar 2026) · Operating margin 16.9% · 100% evidence Valuation 11.3/20 · P/E 23.4× · PEG n/a · 50% evidence Relative strength 11.2/20 · Strength vs its industry (price vs its 52-week average, weekly) n/a · Strength vs NIFTY 500 (same reading) 5.1% · 1 year -12.6% · 25% evidence · 9 of 12 weeks ahead Exact sum: 24.1 + 8.8 + 11.3 + 11.2 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · losing its lead · Evidence leans up · 100% evidence 53.8 out of 100 Growth Capital Valuation Relative 12. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 68% evidence 53.6 out of 100 Growth Capital Valuation Relative 13. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans up · 75% evidence 51.5 out of 100 Growth Capital Valuation Relative 14. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans up · 100% evidence 51.0 out of 100 Growth Capital Valuation Relative 15. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 100% evidence 50.8 out of 100 Growth Capital Valuation Relative 16. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 75% evidence 49.9 out of 100 Growth Capital Valuation Relative 17. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans down · 100% evidence 49.3 out of 100 Growth Capital Valuation Relative 18. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 82% evidence 48.9 out of 100 Growth Capital Valuation Relative 19. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans down · 75% evidence 48.2 out of 100 Growth Capital Valuation Relative 20. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 90% evidence 46.1 out of 100 Growth Capital Valuation Relative 21. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 75% evidence 45.7 out of 100 Growth Capital Valuation Relative 22. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · Evidence leans down · 70% evidence 45.3 out of 100 Growth Capital Valuation Relative 23. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans down · 83% evidence 43.4 out of 100 Growth Capital Valuation Relative 24. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · quiet · Evidence leans down · 85% evidence 43.1 out of 100 Growth Capital Valuation Relative 25. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 43.1 out of 100 Growth Capital Valuation Relative 26. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 43.1 out of 100 Growth Capital Valuation Relative 27. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 57% evidence 40.3 out of 100 Growth Capital Valuation Relative 28. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · turning · Evidence leans down · 67% evidence 38.6 out of 100 Growth Capital Valuation Relative 29. Vishnu Chemicals Ltd this page VISHNU · losing its lead · Evidence leans down · 90% evidence 37.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.4/35 · Revenue 14% · Profit 10.9% · Operating margin change 0 points · 100% evidence Capital efficiency 13.3/25 · ROCE 16.4% (year to Mar 2026) · Operating margin 14.9% · 100% evidence Valuation 8.1/20 · P/E 24.4× · PEG n/a · 50% evidence Relative strength 2.8/20 · Strength vs its industry (price vs its 52-week average, weekly) -11.4% · Strength vs NIFTY 500 (same reading) -7.6% · 1 year 14.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 13.4 + 13.3 + 8.1 + 2.8 = 37.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 71% evidence 34.0 out of 100 Growth Capital Valuation Relative Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Vishnu Chemicals in size? Vishnu Chemicals is the 14th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (at the 18 November 2026 close). Just above it: Fineotex Chemical, Yasho Industries and Tatva Chintan Pharma Chem. Just below it: Grauer & Weil (India), Panama Petrochem and Innovassynth Technologies (India). ### Speciality Chemicals companies close in size 1. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) ₹5,197 crore 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) ₹4,510 crore 3. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) ₹3,857 crore 4. Vishnu Chemicals Ltd ₹3,715 crore 5. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) ₹3,419 crore 6. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) ₹2,564 crore 7. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) ₹1,531 crore [All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies) ### Companies close in size in other industries 1. [Yash Highvoltage Ltd](https://www.sectoralpha.in/stocks/yash-highvoltage-ltd) ₹3,742 crore · Electric Equipment - General 2. [Caliber Mining and Logistics Ltd](https://www.sectoralpha.in/stocks/caliber-mining-and-logistics-ltd) ₹3,723 crore · Mining/Minerals 3. Vishnu Chemicals Ltd ₹3,715 crore 4. [Dalmia Bharat Sugar & Industries Ltd](https://www.sectoralpha.in/stocks/dalmia-bharat-sugar-industries-ltd) ₹3,710 crore · Sugar 5. [Sterling & Wilson Renewable Energy Ltd](https://www.sectoralpha.in/stocks/sterling-wilson-renewable-energy-ltd) ₹3,701 crore · Solar EPC ## What else do people ask about Vishnu Chemicals? ### What is Vishnu Chemicals's share price today? Vishnu Chemicals Ltd's share price is ₹551.95, +14.8% over the past year. The whole company is worth ₹3,713 Cr on the market. In the last 52 weeks it traded between ₹481 to ₹722; today it is 29% of the way up from the low, 6.7% below its 200-day average (as of 18 November 2026). ### What were Vishnu Chemicals's latest quarterly results? Vishnu Chemicals Ltd reported revenue of ₹430 Cr and net profit of ₹36.0 Cr for the Sep 2026 quarter. Revenue rose 7.2% and profit rose 9.1% compared with a year earlier. Earnings per share were ₹5.28. The operating margin was 14.9%, 0.4 percentage points higher than a year earlier (as of 18 November 2026). ### What is Vishnu Chemicals's market cap? Vishnu Chemicals Ltd's market capitalisation is ₹3,713 Cr at a share price of ₹551.95. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026). ### How is Vishnu Chemicals performing? Vishnu Chemicals Ltd's share price is in an uptrend that has just slipped below its 200-day average. In its latest quarter, revenue rose 7.2% and profit rose 9.1% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 4 weeks running (as of 18 November 2026). ### Is Vishnu Chemicals in an uptrend? Yes, the price has been rising for 93 weeks (stage 2 of 4), 6.7% below its 200-day average, and 29% of the way up its 52-week range. A share price tends to move through four phases: moving sideways, rising, stalling and falling (as of 18 November 2026). ### Will Vishnu Chemicals's share price go up? This page does not forecast Vishnu Chemicals Ltd's share price. What it shows instead: the share price is ₹551.95, and it has been rising for 93 weeks. Its P/E of 24.4× is higher than 65% of its own last 11 years (as of 18 November 2026). ### Does Vishnu Chemicals have too much debt? Vishnu Chemicals Ltd has a moderate amount of debt: its debt is 0.49× its equity, and its operating profit is 7 times its interest bill. FY26 borrowings were ₹527 Cr against equity of ₹1,069 Cr. Keep that borrowing in mind when reading the returns on this page (as of 18 November 2026). ### Where is Vishnu Chemicals in its business cycle? Vishnu Chemicals Ltd's FY26 operating margin was 15.7%, against a 13-year range of 11.6% to 18.9%. The latest quarter was 14.9%, the middle of its own range, neither a peak nor a low. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026). ### What could break the Vishnu Chemicals story? Biggest thing to watch: the P/E is higher than 65% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026). ### Is Vishnu Chemicals a stock worth studying right now? What the numbers show: Vishnu Chemicals Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026). ### Is there a Vishnu Chemicals share price forecast for 2026? What management itself guided: DMSO operations from April to June 2027 aiming for 50-60% operating level in first year with short stabilisation. This is research, not advice. We’re not SEBI-registered.